These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37818445)

  • 21. External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan.
    Okano H; Yamamoto R; Iwasaki Y; Irimada D; Konno D; Tanaka T; Oishi T; Nawa H; Yano A; Taniguchi H; Otawara M; Matsuoka A; Yamauchi M
    J Intensive Care; 2024 Feb; 12(1):7. PubMed ID: 38360681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of risk factors for the failure of respiratory support with high-flow nasal cannula oxygen therapy in children with acute respiratory dysfunction: A case-control study.
    Liu J; Li D; Luo L; Liu Z; Li X; Qiao L
    Front Pediatr; 2022; 10():979944. PubMed ID: 36081624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19.
    Ait Hamou Z; Levy N; Charpentier J; Mira JP; Jamme M; Jozwiak M
    Respir Res; 2022 Dec; 23(1):329. PubMed ID: 36463161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics and failure risk factors of sequential high-flow nasal cannula oxygen therapy after weaning from invasive ventilation in patients of surgical intensive care unit].
    Zhao H; Luo J; Lyu J; Wang H; Ji H; An Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):689-693. PubMed ID: 31315724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting the failure of High Flow Nasal Cannula Oxygen therapy in Intensive Care follow-up of COVID-19 Severe Respiratory Failure.
    Fulya Ç; Ersin K; Mehmet G; Yeliz B; Elif B; Kemal S
    Malawi Med J; 2022 Mar; 34(1):37-42. PubMed ID: 37265829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Flow Nasal Cannula Therapy in Patients With COVID-19: Predictive Response Factors.
    Raboni SM; Neves VC; Silva RM; Breda GL; Ceregato AC; Broza TP; de Oliveira G; Melo-Diaz LL; Braga CB; Carraro CF; Arroyo NC; Bardy RF; Devetak GF; Ozawa CM; Graf ME; Dias VL; Ducroquet MA; Nunes DP; Sokoloski CS; Petterle RR
    Respir Care; 2022 Nov; 67(11):1443-1451. PubMed ID: 35944966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis.
    Xu DY; Dai B; Tan W; Zhao HW; Wang W; Kang J
    Ther Adv Respir Dis; 2022; 16():17534666221091931. PubMed ID: 35467449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index.
    Takeshita Y; Terada J; Hirasawa Y; Kinoshita T; Tajima H; Koshikawa K; Kinouchi T; Isaka Y; Shionoya Y; Tada Y; Tsushima K
    Respir Investig; 2022 Jan; 60(1):146-153. PubMed ID: 34772644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
    Chandel A; Patolia S; Brown AW; Collins AC; Sahjwani D; Khangoora V; Cameron PC; Desai M; Kasarabada A; Kilcullen JK; Nathan SD; King CS
    Respir Care; 2021 Jun; 66(6):909-919. PubMed ID: 33328179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study.
    Liu L; Xie J; Wu W; Chen H; Li S; He H; Yu Y; Hu M; Li J; Zheng R; Li X; Qiu H; Tong Z; Du B; Fan E; Yang Y; Slutsky AS
    Lancet Digit Health; 2021 Mar; 3(3):e166-e174. PubMed ID: 33573999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure.
    Xu J; Yang X; Huang C; Zou X; Zhou T; Pan S; Yang L; Wu Y; Ouyang Y; Wang Y; Xu D; Zhao X; Shu H; Jiang Y; Xiong W; Ren L; Liu H; Yuan Y; Qi H; Fu S; Chen D; Zhang D; Yuan S; Shang Y
    Front Med (Lausanne); 2020; 7():607821. PubMed ID: 33425951
    [No Abstract]   [Full Text] [Related]  

  • 32. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.
    Roca O; Caralt B; Messika J; Samper M; Sztrymf B; Hernández G; García-de-Acilu M; Frat JP; Masclans JR; Ricard JD
    Am J Respir Crit Care Med; 2019 Jun; 199(11):1368-1376. PubMed ID: 30576221
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study.
    Mellado-Artigas R; Mujica LE; Ruiz ML; Ferreyro BL; Angriman F; Arruti E; Torres A; Barbeta E; Villar J; Ferrando C;
    J Intensive Care; 2021 Mar; 9(1):23. PubMed ID: 33673863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily ROX index can predict transitioning to mechanical ventilation within the next 24 h in COVID-19 patients on HFNC.
    de Carvalho VCP; da Silva Guimarães BL; Fujihara MTF; Ceotto VF; Turon R; Lugon JR; Gismondi RAOC
    Am J Emerg Med; 2023 Nov; 73():160-165. PubMed ID: 37688983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Associated With Non-invasive Oxygen Therapy Failure in COVID-19 Pneumonia: A Single Center, Retrospective Study in a Tertiary Hospital in North India.
    L S; Sehgal IS; Kajal K; Kataria S; Premkumar M; Singla K; Mahajan V; Gorla DK; Puri GD
    Cureus; 2022 Sep; 14(9):e29721. PubMed ID: 36340560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of high-flow nasal cannula oxygen on patients with chronic obstructive pulmonary disease and mild hypercapnia: a retrospective cohort study based on the Medical Information Mart for Intensive Care-IV database].
    Liu T; Zhao Q; Shi Z; Du B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):686-691. PubMed ID: 34296687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of Respiratory Rate-Oxygenation Index in Patients With COVID-19-Related Respiratory Failure.
    Myers LC; Mark D; Ley B; Guarnieri M; Hofmeister M; Paulson S; Marelich G; Liu VX
    Crit Care Med; 2022 Jul; 50(7):e638-e642. PubMed ID: 35120044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.
    Roca O; Messika J; Caralt B; García-de-Acilu M; Sztrymf B; Ricard JD; Masclans JR
    J Crit Care; 2016 Oct; 35():200-5. PubMed ID: 27481760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19.
    Chavarria AP; Lezama ES; Navarro MG; Vazquez RRV; Bello HH; Gascon JL; Juárez LM; Avendaño MA; Gonzalez LER; Ville Benavides R; Wyssmann RVÁ; Ortiz BS; de la Cerda MLR; Castañeda LM; Martinez-Juarez LA; Gallardo-Rincón H; Tapia-Conyer R
    Ther Adv Infect Dis; 2021; 8():20499361211042959. PubMed ID: 34497714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.